United States 114th Congress Status: Died 1 D cosponsors

HR 1462 — Protecting Our Infants Act of 2015

Last action — Indefinitely postponed by Senate by Unanimous Consent. (consideration: CR S5195)

Track this bill free

No card. One bill, free forever — alerts when it moves.

  1. ✓
    Introduced
  2. Died in session

This bill died with 114th Congress. It reached “Introduced” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.

Summary

Protecting Our Infants Act of 2015 (Sec. 3) This bill requires the Agency for Healthcare Research and Quality to report on prenatal opioid abuse and neonatal abstinence syndrome (symptoms of withdrawal in a newborn). (An opioid is a drug with effects similar to opium, such as heroin or certain pain medications.) The report must include: an assessment of existing research on neonatal abstinence syndrome; an evaluation of the causes, and barriers to treatment, of opioid use disorders among women of reproductive age; an evaluation of treatment for pregnant women with opioid use disorders and infants with neonatal abstinence syndrome; and recommendations on preventing, identifying, and treating opioid dependency in women and neonatal abstinence syndrome. (Sec. 4) The Department of Health and Human Services must review its activities related to prenatal opioid use and neonatal abstinence syndrome and develop a strategy to address gaps in research and programs. (Sec. 5) The Centers for Disease Control and Prevention must provide technical assistance to states to improve neonatal abstinence syndrome surveillance and make surveillance data publicly available.

Bill Text

We don't have the full text on file for this bill yet.

Read HR 1462 on the official United States source →

Action History

  1. Indefinitely postponed by Senate by Unanimous Consent. (consideration: CR S5195)

  2. Received in the Senate.

  3. Motion to reconsider laid on the table Agreed to without objection.

  4. On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H5798-5799)

  5. DEBATE - The House proceeded with forty minutes of debate on H.R. 1462.

  6. Considered under suspension of the rules. (consideration: CR H5798-5801)

  7. Mr. Guthrie moved to suspend the rules and pass the bill.

  8. Placed on the Union Calendar, Calendar No. 185.

  9. Reported by the Committee on Energy and Commerce. H. Rept. 114-244.

  10. Ordered to be Reported by Voice Vote.

  11. Committee Consideration and Mark-up Session Held.

  12. Forwarded by Subcommittee to Full Committee by Voice Vote .

  13. Subcommittee Consideration and Mark-up Session Held.

  14. Referred to the Subcommittee on Health.

  15. Referred to the House Committee on Energy and Commerce.

  16. Introduced in House

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

1 sponsors · 0 co-sponsors · 546 not signed on

Sponsors (1)

Co-sponsors (0)

None.

Not signed on (546)

546 members have not signed on to this bill.

Show all 546 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does HR 1462 do?
Protecting Our Infants Act of 2015 (Sec. 3) This bill requires the Agency for Healthcare Research and Quality to report on prenatal opioid abuse and neonatal abstinence syndrome (symptoms of withdrawal in a newborn). (An opioid is a drug with effects similar to opium, such as heroin or certain pain medications.) The report must include: an assessment of existing research on neonatal abstinence syndrome; an evaluation of the causes, and barriers to treatment, of opioid use disorders among women of reproductive age; an evaluation of treatment for pregnant women with opioid use disorders and infants with neonatal abstinence syndrome; and recommendations on preventing, identifying, and treating opioid dependency in women and neonatal abstinence syndrome. (Sec. 4) The Department of Health and Human Services must review its activities related to prenatal opioid use and neonatal abstinence syndrome and develop a strategy to address gaps in research and programs. (Sec. 5) The Centers for Disease Control and Prevention must provide technical assistance to states to improve neonatal abstinence syndrome surveillance and make surveillance data publicly available.
Who sponsors HR 1462?
HR 1462 is sponsored by Katherine Clark (D).
What is the current status of HR 1462?
This bill died with 114th Congress. It reached “Introduced” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track HR 1462?
Track HR 1462 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HR 1462

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of HR 1462

Last checked for changes about 18 hours ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →